AdventHealth’s Physicians and Scientists Discuss Research Designed to Explore the Mystifying Effects of Exercise

Dr. Steven Smith and Bret Goodpaster, Ph.D side by side headshots
Dr. Steven Smith, senior vice president and chief scientific officer at AdventHealth (left) and Bret Goodpaster, Ph.D., senior scientific director at AdventHealth’s Translational Research Institute (right)

We know exercise is good for health, but there isn’t a one-size-fits-all prescription when it comes to individual needs. Everyone is different in terms of how their bodies fight diseases and respond to therapies. The physicians and scientists at AdventHealth are working on some of the biggest problems in health care, including uncovering the mystifying effects of exercise.

In this episode of the Inspiring Wholeness podcast, Dr. Steven Smith, senior vice president and chief scientific officer at AdventHealth and Bret Goodpaster, Ph.D., senior scientific director at AdventHealth’s Translational Research Institute, discuss partnering with the National Institute of Health on a 10-year study titled Molecular Transducers of Physical Activity Consortium (MoTrPAC).

The goal of the research is to discover more about why the body breaks; how physical activity can improve brain health, protect the heart, prevent diabetes, influence cancer and promote other health benefits; and why people’s bodies respond differently to exercise.

Listen now and subscribe so you never miss a new episode.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma

AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...

Read Article about "New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma"
View More Articles